Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Po Nien Liao"'
Autor:
Chun-Chia Cheng, Po-Nien Liao, Ai-Sheng Ho, Ken-Hong Lim, Jungshan Chang, Ying-Wen Su, Caleb Gon-Shen Chen, Ya-Wen Chiang, Bi-Ling Yang, Huan-Chau Lin, Yu-Cheng Chang, Chun-Chao Chang, Yi-Fang Chang
Publikováno v:
Journal of Biomedical Science, Vol 25, Iss 1, Pp 1-12 (2018)
Abstract Background Cancer stem cells are capable of undergoing cell division after surviving cancer therapies, leading to tumor progression and recurrence. Inhibitory agents against cancer stem cells may be therapeutically used for efficiently eradi
Externí odkaz:
https://doaj.org/article/6fa8fbb263aa47dc8b21de866be2cfc8
Autor:
Ying‐Wen Su, Wen‐Yu Huang, Huan‐Chau Lin, Po‐Nien Liao, Ching‐Yung Lin, Xiang‐Yu Lin, Sing‐Han Huang, Yi‐Ting Chen, Pao‐Shu Wu
Publikováno v:
Journal of Oral Pathology & Medicine. 52:245-254
Accumulating evidence shows that high expression of casein kinase 2 (CK2) and phosphorylated acetyl CoA carboxylase (pACC) in patients with squamous cell carcinoma of the head and neck (SCCHN) correlates with decreased survival rates. Computational a
Autor:
Huan-Chau Lin, Caleb Gon-Shen Chen, Ming-Chih Chang, Wei-Ting Wang, Chen Wei Kao, An-Chi Lo, Nai-Wen Su, Yu-Cheng Chang, Yi-Hao Chiang, Kuei-Fang Chou, Po-Nien Liao, Guan-Jhe Cai, Hung-I Cheng, Johnson Lin, Yi-Fang Chang, Ruey-Kuen Hsieh, Ken-Hong Lim
Publikováno v:
International Journal of Gerontology, Vol 7, Iss 1, Pp 40-44 (2013)
Background: Essential thrombocythemia (ET) is classified as a chronic myeloproliferative neoplasm. JAK2 V617F mutation is found in about 50–60% patients with ET. We aim to determine the prevalence of JAK2 V617F mutation and its association with phe
Externí odkaz:
https://doaj.org/article/5f37be7a6b3a4ffc9382b114777bd644
Autor:
Ai Sheng Ho, Yu-Cheng Chang, Ya Wen Chiang, Bi Ling Yang, Chun Chao Chang, Po Nien Liao, Yi Fang Chang, Ken-Hong Lim, Jungshan Chang, Ying Wen Su, Caleb Gon-Shen Chen, Huan Chau Lin, Chun Chia Cheng
Publikováno v:
Journal of Biomedical Science, Vol 25, Iss 1, Pp 1-12 (2018)
Journal of Biomedical Science
Journal of Biomedical Science
Background Cancer stem cells are capable of undergoing cell division after surviving cancer therapies, leading to tumor progression and recurrence. Inhibitory agents against cancer stem cells may be therapeutically used for efficiently eradicating tu
Autor:
Chun-Chia Cheng, Po-Nien Liao, Ai-Sheng Ho, Ken-Hong Lim, Jungshan Chang, Su, Ying-Wen, Chen, Caleb, Chiang, Ya-Wen, Bi-Ling Yang, Huan-Chau Lin, Chang, Yu-Cheng, Chun-Chao Chang, Chang, Yi-Fang
Table S3. Detailed measurement of cell viability in therapeutic screening against HCT116 and HT29 cells. (DOCX 632Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::125fb00e3f45fc9efc4e879d5c0271b2
Autor:
Chun-Chia Cheng, Po-Nien Liao, Ai-Sheng Ho, Ken-Hong Lim, Jungshan Chang, Su, Ying-Wen, Chen, Caleb, Chiang, Ya-Wen, Bi-Ling Yang, Huan-Chau Lin, Chang, Yu-Cheng, Chun-Chao Chang, Chang, Yi-Fang
Table S2. Upregulated genes associated with the Wnt signaling pathway in HCT116-derived tumorspheres (analyzed using PANTHER, http://pantherdb.org /). (DOCX 14Â kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43510655ea6784d29ee50c5e06e37f91
Autor:
Po-Nien Liao, Hung-I Cheng, Chen Wei Kao, Ken-Hong Lim, Huan-Chau Lin, Wei-Ting Wang, Johnson Lin, Ming-Chih Chang, Yi-Hao Chiang, Yu-Cheng Chang, Guan-Jhe Cai, Nai-Wen Su, Ruey-Kuen Hsieh, Yi-Fang Chang, Caleb Gon-Shen Chen, Kuei-Fang Chou, An-Chi Lo
Publikováno v:
International Journal of Gerontology, Vol 7, Iss 1, Pp 40-44 (2013)
Summary Background Essential thrombocythemia (ET) is classified as a chronic myeloproliferative neoplasm. JAK2 V617F mutation is found in about 50–60% patients with ET. We aim to determine the prevalence of JAK2 V617F mutation and its association w